Silver nanoparticles have been studied as an alternative for treatment of microbial infections and leishmaniasis, without promoting induction of microbial or parasite resistance. In this study, chitosan-based silver nanoparticles were synthesized from silver nitrate (AgNO 3 ), sodium borohydride as a reducing agent, and the biopolymer chitosan as a capping agent. The chitosanbased silver nanoparticles were characterized by ultraviolet-visible, Fourier transform infrared, dynamic light scattering, zeta potential, atomic force microscopy, and transmission electron microscope. The antibacterial assay was performed by determination of the minimum inhibitory 
Introduction
Chitosan is a polysaccharide biopolymer derived from chitin, whose unique chemical structure forms a linear polycation with high charge density and reactive chemical groups, as well as excellent biocompatibility and manufacturing properties. 1 Therefore, the use of chitosan has been investigated for several technological and biomedical applications, such as pharmaceutical polymeric matrices for controlled drug release, due to its capability to dissolve non-water soluble drugs, and its long-lasting bioavailability, as well as its low toxicological, allergenic, and antimicrobial properties. 2, 3 A wide range of chemical groups are able to react with chitosan, such that chemical modifications can be used to either add specific functionalities or change biological or physical properties of the biopolymer. 4 In this sense, when structured at nanometric dimensions, silver possess different optical and biological properties which have been widely explored, 5 such as antibacterial and anticancer properties, 6 in the development of controlled drug release systems. 7 Currently, silverinduced biological properties are also under investigation for treatment of infected wounds and burns. 8, 9 Likewise, the use of chitosan-based colloids has been reported for systemic release of several compounds and for synthesis of nanoparticles using metals, such as silver. 10, 11 The unique catalytic and surface characteristics of chitosan have a pivotal role in enhancing the antibacterial effect induced by silver nanoparticles. 10, 11 The search for new antibacterial agents, especially with effects against resistant strains, represents a current global problem. 12 Furthermore, silver-doped metallic nanoparticles have also been studied against leishmaniasis, 13, 14 a serious neglected disease with few and ever less effective options for chemotherapy treatment. 15 Therefore, this work focuses on the synthesis and characterization of chitosan-based silver nanoparticles (AgNPs-chitosan), and evaluates their effect against resistant bacteria and promastigote forms of Leishmania amazonensis.
Materials and methods

Synthesis and characterization of silver nanoparticles
The synthesis of Ag nanoparticles stabilized with chitosan was performed according to Wei et al. 10 with minor modifications. Silver nitrate (AgNO 3 ) and sodium borohydride (NaBH 4 ) were purchased from Aldrich Chemical Co. and used without further purification. Chitosan was purchased from Sigma-Aldrich. The synthesis of AgNPs-chitosan was performed in a glass reactor with magnetic stirring. Briefly, 7 mL of 1 mM AgNO 3 solution was added to 7 mL of 0.05% chitosan solution (w/v), which was prepared by dissolving the chitosan in 1% aqueous acetic acid. To reduce the silver salt, a measured amount of fresh NaBH 4 stock solution (0.1 M) was added to the AgNO 3 solution containing chitosan as a capping agent. This solution acquired a yellow-gray turbid aspect after the addition of NaBH 4 , and then a colloidal suspension was formed.
The synthesis of silver nanoparticles was monitored by ultraviolet-visible (UV-vis)-nearinfrared spectroscopy (NIR) scanning spectrophotometer (UV-3101 PC; Shimadzu, Japan) at the range of 300-800 nm. Particle size and zeta potential (ζ) measurements were carried out using a Malvern Zetasizer Nano, Model ZS 3600. The hydrodynamic diameter was measured by dynamic light scattering (DLS) at wavelength of 633 nm and fixed scattering angle of 173°. Particle size was measured considering the particle as spherical shape. Each sample was measured three times for two replicate samples at a constant temperature of 25°C ± 1°C. All infrared measurements were performed on a Fourier transform infrared (FTIR) spectrophotometer (FT-IR System Spectrum BX; PerkinElmer) using the attenuated total reflection (ATR) technique in the spectral range from 4000 to 650 cm −1 .
To quantify the percentage of silver in solution, the atomic absorption spectroscopy (VarianModel AA240FS) was used, with a wavelength of 328.1 nm and multielement lamp (Varian no. 5610108700). The reading was held in atomic absorption flame with oxygen and acetylene gases. Samples for transmission electron microscope (TEM) analysis were prepared by depositing 10 µL of the colloidal suspensions on carbon copper grids, washing twice with 10 mL of Milli-Q water, followed by air-drying. TEM was performed by a Hitachi H-8100 microscope operating at 200 kV. Histograms of the nanoparticle size distribution were generated with ImageJ ® , a freely available image analysis program (http://rsb.info.nih.gov/ij/) and Origin 9.0 ® . Atomic force microscopy (AFM) samples were prepared by drying a drop of nanoparticle solution onto a freshly cleaved mica surface. Samples were analyzed by an AFMWorkshop TT-AFM (Signal Hill, USA) on vibrating mode, using a scanner of 15 × 15 × 7 µm. AppNano ACT probes were used at an oscillation frequency close to 300 kHz, and the images were analyzed using the Gwyddion ® 2.42 package.
Biological assays
Antibacterial evaluation. To evaluate the antibacterial effect of AgNPs-chitosan, the following microorganisms were used: Gram-positive methicillin-resistant Staphylococcus aureus (MRSA) ATCC 43300 and the Gram-negative organisms extended-spectrum beta-lactamases (ESBL) Escherichia coli ATCC 35218 and Klebsiella pneumoniae ATCC 700603. The microorganisms were cultured under aerobic conditions in Mueller-Hinton agar at 37°C for 24 h. Afterward, a suspension of bacterial strains was prepared in 0.85% NaCl solution, with an optical density of 0.5 McFarland (1 × 10 8 colony-forming unit (CFU)/mL), and then used as the inoculum in the experiment.
The antibacterial assay was performed by determination of the minimum inhibitory concentration (MIC) of AgNPs-chitosan, following the method of Quelemes et al. 16 The strains (concentration of 5 × 10 5 CFU/mL) were exposed to twofold dilution series of the AgNPs-chitosan (0.42-27 µg Ag/mL) in a 96-well microdilution plate. The MICs of chitosan, AgNO 3 , and standard antibiotics effective against the bacteria were also determined. At the end of the microdilution, the tested concentrations ranged from 0.42 to 27 µg Ag/mL for AgNO 3 , 1.95 to 125 µg/mL for chitosan, and 0.5 to 16 µg/mL for antibiotics. The MIC was defined as the lowest concentration of agent which is able to restrict the visible bacterial growth in the culture media. All assays were performed in triplicate.
Antileishmanial evaluation against promastigote forms of L. amazonensis. Leishmania amazonensis (IFLA/BR/67/PH8) was maintained as amastigotes over several weekly passages in Swiss mice and in vitro as promastigotes at 26°C in supplemented Schneider's medium, pH 7.0 (10% heatinactivated fetal bovine serum (FBS), 100 U/mL penicillin, and 100 µg/mL streptomycin), as previously described. 17 The inhibition of parasite growth was assayed using the resazurin (alamarBlue ® ) colorimetric assay. 18, 19 Briefly, promastigotes in the logarithmic growth phase were cultured in 96-well cell culture plates at 1 × 10 6 parasites per well in 100 µL of Schneider's medium with increasing concentrations of AgNPs-chitosan, chitosan, and AgNO 3 . These agents were prepared at a twofold dilution series, with concentrations ranging from 0.42 to 27 µg Ag/mL for AgNPs-chitosan, 1.95 to 125 µg/mL for chitosan, and 0.42 to 27 µg Ag/mL for AgNO 3 . The plates were incubated for 48 h in a biological oxygen demand (BOD) incubator at 26°C. Cell viability was measured by adding 20 µL of resazurin (1 mM) followed by incubation for 6 h in BOD at 26°C. The absorbance was measured using an ELISA plate reader (Biosystems model ELx800) at 550 nm. Schneider's medium in the presence of 1 × 10 6 of Leishmania was used as a negative control, being considered as 100% of the parasite viability.
Cytotoxic effect and determination of the selective index. Male and female BALB/c mice (4-5 weeks old) were maintained under controlled temperature (24°C ± 1°C) and light conditions (12-h lightdark cycle). Murine peritoneal macrophages were collected 5 days after intraperitoneal administration of 3% thioglycollate (1.5 mL). The protocols were approved by the Animal Experimentation Ethics Committee from Federal University of Piauí, permission no. 008/12) and were carried out according to the current guidelines for the care of laboratory animals and the ethical guidelines for investigation of experimental pain in conscious animals (NIH publication 85-23, revised in 1985).
Cytotoxicity evaluation was carried out in 96-well plates using the MTT assay. Approximately 1 × 10 6 macrophages per well were incubated in 100 µL of supplemented RPMI 1640 medium at 37°C and 5% CO 2 for 4 h for cell adhesion. Non-adherent cells were removed by washing with RPMI 1640 medium. Then, AgNPs-chitosan, AgNO 3 , and chitosan solutions were diluted in supplemented RPMI 1640 medium for testing cell viability at a two-fold dilution series, at concentrations ranging from 0.42 to 27 µg Ag/mL for AgNPs-chitosan, 1.95 to 125 µg/mL for chitosan, and 0.42 to 27 µg Ag/mL for AgNO 3 . The plates were incubated at 37°C with 5% CO 2 for 2 days. Following incubation, cytotoxicity was assessed by adding 10 µL of MTT (5 mg/mL) for 4 h. The supernatant was discarded, and the formazan crystals were dissolved by addition of 100 µL of dimethyl sulfoxide (DMSO). Finally, the absorbance was measured at 550 nm using a microplate reader.
The selectivity index (SI) of each treatment was calculated by the ratio between the mean cytotoxicity concentration (CC 50 ) against murine macrophages and the mean inhibitory concentration (IC 50 ) of promastigotes' growth.
Antileishmanial evaluation against amastigote forms of L. amazonensis. The peritoneal macrophages were isolated from the peritoneum of BALB/c mice by injecting the cold phosphate-buffered saline (PBS) and re-aspiration. Isolated macrophages were seeded on a glass coverslip in tissue culture 12-well plates and incubated at 37°C with 5% CO 2 for 24 h. Non-adherent cells were removed by two washes with PBS. Adherent macrophages were infected with the stationary growth phase of promastigote forms of L. amazonensis at a parasite-macrophage ratio of 10:1 and then the plate was incubated for 24 h at 37°C with 5% CO 2 . Non-internalized promastigotes were removed by washing with cold PBS. Infected macrophages were further incubated in the presence or absence (negative control group) of concentrations of the AgNPs-chitosan and controls for 24 and 48 h. Infected macrophages in coverslip were stained with Giemsa stain, and the amastigotes inside the macrophage (100 macrophages per coverslip) were counted under a light microscope. 20 Statistical analysis. All the experimental protocols were performed in triplicate and in three independent experiments. Differences between groups were analyzed by one-way analysis of variance (ANOVA) followed by Bonferroni's post hoc test using GraphPad Prism ® software version 5.0, considering the differences were statistically significant when p<0.05. The IC 50 and CC 50 values were calculated using probit analysis (SPSS program, version 20.0) with a confidence level of 95% (p<0.05).
Results and discussion
Characterization of silver nanoparticles
Chitosan is a polysaccharide obtained by partial deacetylation of chitin (Figure 1 ). The chitosan in solution is protonated and positively charged and is able to be adsorbed onto the surfaces of metal nanoparticles, stabilizing and protecting the nanoparticles.
Silver nanoparticles were obtained using chitosan as stabilizing agent. The formation of AgNPschitosan was monitored by UV-vis absorption spectra at 300-800 nm, and a plasmon absorption band, characteristic of silver nanoparticles, was observed at 400 nm, as shown in Figure 2(a) . The solution at the AgNPs-chitosan resulted in a final Ag 0 concentration of 0.74 mM, as confirmed by the atomic absorption test.
Silver nanoparticles absorb radiation in the visible region of the electromagnetic spectrum (ca. 380-450 nm), due to the excitation of surface plasmon vibrations which is responsible for the striking yellow-brown color (Figure 2(a) ) of silver nanoparticles. Figure 1 (b) also presents a particle size distribution obtained from DLS data with the mean particle diameter (d) = 35.6 ± 2.27 nm obtained by DLS.
The average zeta potential (ζ) of the nanoparticles was determined by measuring their electrophoretic mobility, and the values were converted into ζ-potential (mV). The capping of cationic polysaccharide on the surface of nanoparticles was confirmed by zeta potential measurement (+55.0 mV) and is responsible for the electrostatic stability. The average diameters observed by TEM were lower than the corresponding hydrodynamic diameter (36 nm for DLS and 15 nm for TEM; Figure 3(a) and (b) ).
These observations are normal and mostly reflect the increased sensitivity of DLS to larger particles, as well as small particle aggregates can be detected in solution, while for TEM only single particles can be counted. On the other hand, the AFM imaging demonstrated a mean diameter of 17.5 nm with a standard deviation of 3.35 nm (Figures 4(a) and (b) ). This result is in accordance with TEM results. Unlike TEM, AFM is equally sensitive to soft organic materials, such as chitosan and metallic particles. Therefore, the polymeric coating of the nanoparticles does not increase significantly their size. Figure 5 illustrates FTIR spectra of chitosan and AgNPs-chitosan materials synthesized with 0.5 M AgNO 3 . The broad absorption peak at 4000-500 cm −1 is the merged characteristic bands for OH. The NH 2 groups 21 and CONH 2 absorption band are also observed near 1657 cm −1 in the FTIR spectrum of chitosan. 22 The shift was observed from 1657 cm −1 in the Ag-loaded chitosan spectra. At the same time, the N-H bending vibration bands at about 1568 cm −1 were shifted to 1560 cm −1 along with a decrease in intensity. This shift may indicate the binding of AgNPs to an N-H bond of chitosan. 10 The presence of the 1704 cm −1 signal may indicate that the reduction in the silver ions is coupled to the oxidation of the hydroxyl groups in the chitosan molecule. The bands near 1080-1025 cm −1 are attributed to νCO of the ring COH, COC, and CH 2 OH. The band at 3419 cm −1 corresponds to the combined peaks of the NH 2 and OH group stretching vibration in chitosan.
Biological assays
The effects of AgNPs-chitosan against resistant bacterial strains, promastigotes forms of L. amazonensis, and murine macrophages were evaluated. The concentration of silver nanoparticles and AgNO 3 was presented in micrograms silver per milliliter. For the AgNPs-chitosan solution, besides the reduced silver concentration, the respective concentration of chitosan (µg/mL) present in the respective dilution is shown in parentheses, to support the comparison of biological effects among the different agents present.
In Table 1 , the AgNPs-chitosan induced a potent effect against all tested microorganisms at MICs ranging between 1.69 (7.81) and 3.38 (15.63) µg Ag/mL. These values are lower than the MICs obtained for chitosan and AgNO 3 solutions. This excellent activity seems to be related to a synergistic effect between the AgNPs and chitosan solution used in stabilization.
The antimicrobial property of chitosan and its derivatives have been attracting great attention from researchers, and studies have reported that the chitosan by itself 23 possess activity against filamentous fungi, yeasts, and bacteria, being more active against Gram-positive than Gramnegative bacteria. [24] [25] [26] [27] [28] [29] The main suggested mechanism are related to (a) the binding of cationic chitosan to sialic acid in phospholipids, causing a membrane-disrupting effect, and consequently restraining the movement of microbiological substances, 30 and (b) the penetration of oligomeric chitosan into the cells, where they interact with cellular DNA of fungi and bacteria, consequently inhibiting DNA transcription, as well as RNA and protein synthesis. [31] [32] [33] [34] Several studies have reported that AgNPs induced strong antimicrobial activity against the most microorganisms, including bacteria, fungi, and viruses. In their review article, Prabhu and Poulose 35 reported there are various theories regarding the mechanisms of action of silver nanoparticleinduced microbicidal effects: (a) the nanoparticles can be fixed on the surface and cause the changes in the permeability of the cell membrane and death of the microorganism; (b) the nanoparticles, in contact with the microorganisms, promote the generation of free radicals, then resulting in the formation of pores through the microorganism membrane, loss of osmoregulation, and cell death; 36, 37 and (c) the nanoparticle release silver ions 38 which could interact with the thiol groups of many vital enzymes, 39 as well as with sulfur and phosphorus present in DNA and proteins, inactivating these molecules and leading to death of the microorganism. Corroborating our findings, in recent publications, chitin/chitosan/AgNP composites have enhanced antimicrobial activities against microbial pathogens (bacteria, fungi, and virus). [40] [41] [42] Comparative studies showed that AgNPs-chitosan composite is much more effective against bacteria than pure chitosan. 10, 41, 42 Furthermore, Kumar-Krishnan et al. 43 related that synergistic effect of AgNPs and Ag + ions improving antibacterial effect as well as chitosan help stabilize the AgNPs and prevent AgNPs' agglomeration, also conferring positive charges to nanoparticles' surface, enhancing their binding to the negative charges present in the bacterial cell wall.
The antileishmanial activity of the AgNPs-chitosan, chitosan, and AgNO 3 ( Figure 6 ) against promastigote forms of L. amazonensis was assessed by resazurin assay. The AgNO 3 induced a concentration-dependent anti-Leishmania activity, sacrificing more than 50% of the promastigotes exposed at concentrations from 1.69 µg/mL (Figure 6(a) ). Chitosan presented leishmanicidal activity at concentrations from 7.81 µg/mL, sacrificing more than 50% of promastigotes at concentrations of 15.63 µg/mL (Figure 6(b) ). Interestingly, this activity was lower than the AgNPs-chitosan-induced leishmanicidal activity (Figure 6(c) ), where concentrations from 0.84 (3.91) µg/mL sacrificed more than 50% of the promastigotes. As shown in Figure 3 , AgNO 3 , chitosan, and AgNPs-chitosan promoted concentration-dependent anti-Leishmania activity. Overall, the effect of chitosan-capped nanoparticles against Leishmania was slightly stronger than the same concentration of chitosan alone.
Studies conducted by Said et al. 44 revealed a decrease by 90.6% of the number of Giardia lamblia cysts in infected mice and treated with silver nanoparticles and chitosan. However, there is a lack of information about antileishmanial activity of silver nanoparticles alone or together with chitosan. 45, 46 Allahverdiyev et al. 45 determined antileishmanial effects of AgNPs on Leishmania tropica by examining their effects on various cellular parameters of promastigote and amastigote forms. They used a concentration of 200 µg/mL of AgNPs and demonstrated the most significant antileishmanial effects occurred by inhibiting the proliferation and metabolic activity of promastigotes and inhibited the survival of amastigotes in host cells. Furthermore, Ribeiro et al. 47 developed a nanoparticle system containing chitosan, chondroitin sulfate, and amphotericin B and then evaluated its antileishmanial activity against in vitro promastigote and in vivo amastigote forms of L. amazonensis and Leishmania infantum, to develop a less toxic amphotericin B delivery system. In this report, cells infected with L. amazonensis and later treated with chitosan and chitosan-based nanoparticles induced a significant reduction in parasite numbers by 24% and 55%, respectively. These findings are consistent with our results showing activity against Leishmania at concentrations of 31.25 µg/mL chitosan and 6.75 (31.25) µg/mL chitosan nanoparticles leading to death of 100% of the parasites. Figure 3 shows the cytotoxic effects of the (a) AgNO 3 , (b) chitosan, and (c) AgNPs-chitosan against murine macrophages as a model for mammalian cells. The cytotoxic effects of exposure to ionic silver diminished the MTT reduction capacity of the macrophages, with 80% reduction in activity seen in silver concentrations from 1.69 µg/mL (Figure 7(a) ). The chitosan showed cytotoxic effect at concentrations from 15.63 µg/mL (concentrations able to sacrifice 100% of Leishmania promastigotes). However, the concentrations from 7.81 µg/mL, which was able to sacrifice 40% of Leishmania promastigotes (Figure 7(b) ), did not show cytotoxicity against murine macrophages (Figure 7(b) ). Moreover, the AgNPs-chitosan showed cytotoxic effect at all tested concentrations. However (Figure 4(c) ), there was a significant decrease in this effect with a decrease in concentration, reaching 80% viability of macrophages at concentrations of 0.84 (3.91) µg/mL, corresponding to the concentration able to sacrifice 46% of the promastigotes ( Figure 3(c) ). Overall, chitosan was found to be considerably less cytotoxic than the AgNO 3 , and chitosan-AgNPs demonstrated intermediate toxicity.
Several studies in the literature have demonstrated that ionic silver and AgNPs possess both antimicrobial and anti-inflammatory activities, [48] [49] [50] [51] with a marked potential for application in the treatment of various related diseases. 35 However, the cytotoxic effect of nanoparticles is still controversial. Some studies have reported mild or no cytotoxic effect, and other studies have conversely reported moderate to high cytotoxic effects against mammalian cells. Ribeiro et al. 47 have previously demonstrated that chitosan and chitosan-based nanoparticles showed no significant cytotoxicity against mammalian cells at the highest concentration of 100 µg/mL. Interestingly, the percentages of infected macrophages were 66% and 39% after treatment with chitosan and AgNPs-chitosan, respectively. Otherwise, Jebali and Kazemi 46 reported that the nanoparticles promote high cytotoxicity against macrophages, despite its potential antileishmanial activity. On the other hand, some studies have shown that the cytotoxic effect of a compound evaluated by in vitro assays is not always observed in in vivo studies, where the toxicological effects could be influenced by the administration route, among other differences. Furthermore, in their previous studies, Ong et al. 52 have demonstrated that while AgNP-containing chitosanbased wound dressings promote in vitro cytotoxicity, they satisfactorily perform in vivo wound healing effect. Table 2 summarizes the results of the anti-Leishmania activity against promastigote forms of L. amazonensis, cytotoxic effects against mammalian cells, and SI values calculated for chitosan, AgNPs, and AgNPs-chitosan. Based on the IC 50 against promastigotes, chitosan induced a leishmanicidal effect similar to the AgNPs-chitosan IC 50 . However, chitosan was less cytotoxic against macrophages when compared with the AgNPs-chitosan. Interestingly, the high cytotoxicity promoted by AgNO 3 is markedly decreased when the silver is nanostructured with chitosan. Besides, the evaluation of the cytotoxic effect of AgNPs against promastigotes and macrophages demonstrates that the AgNPs showed a higher cytotoxic effect than the chitosan either alone or as a part of the nanoparticles' composition.
The intracellular amastigote forms are the life stage responsible for clinical manifestations of leishmaniasis, occurring as an intracellular amastigote in the mammalian host and as promastigotes only in the intestine of the sand fly vector. 53 Therefore, considering the anti-Leishmania potential of AgNPs-chitosan, its effects against macrophage-internalized amastigote forms of L. amazonensis was evaluated. The AgNPs-chitosan was able to promote a marked decrease in internalized amastigotes in infected macrophages (Table 3) . Besides, AgNO 3 (27 µg/mL) and chitosan (125 µg/ mL) had no activity until the maximum concentration tested in parentheses.
Conclusion
AgNPs-chitosan were synthesized and characterized in this work and presented a marked effect against resistant Gram-positive and Gram-negative pathogenic bacteria. Likewise, AgNPschitosan presented less cytotoxicity than silver alone and was more active against L. amazonensis than chitosan alone. Thus, these results demonstrate that the AgNPs-chitosan represent a promising alternative for the treatment of microbial infections and leishmaniasis.
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